Submit Manuscript

International Journal of Cancer Research

Year: 2011 | Volume: 7 | Issue: 1 | Page No.: 8-24
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend

Total views 223

Authors

Hanan Mohamed Abd ElMoneim

Heba Mohamed Tawfik

Yaser Makram El Sherbiny

Ehab Rifat Tawfiek

Keywords

This study assessed 110 urothelial carcinomas to determine frequency of Her2/neu overexpression in relation with gene amplification and association between Her2/neu and Cox-2 status and clinicopathologic features. Paraffin-embedded tissues of transurethral resection or cystectomy were evaluated by immunohistochemistry, using antibodies against Her2/neu and Cox-2. All samples with Her2/neu overexpression were evaluated by Florescent in situ Hybridization. It was noticed that overexpression of Her2/neu was seen in 52 patients (47.3%). Her2/neu expression was positive in 19 (46.3%) of 41 squamous cell carcinoma and in 33 (47.8%) of 69 transitional cell carcinoma. Her2/neu overexpression in high grade tumors was statistically significant when compared with low grade (p<0.01). Her2/neu gene amplification was found in 11.5% (6 of 52) of high grade transitional cell carcinoma with muscle invasion of highly expressing Her2/neu protein. Expression of Cox-2 was observed in 58 (52.7%) of the patients. Cox-2 was expressed in 34 (49.3%) of transitional cell carcinoma and in 24 (58%) of squamous cell carcinoma. Cox-2 expression was significantly positive in high grade bladder transitional cell carcinoma than in low grade (p<0.05). Also, there was a significant difference in Cox-2 expression level between superficial and invasive tumors (p<0.05). There is a significant correlation between Her2/neu protein expression and Cox-2.
PDF Fulltext XML References Citation

How to cite this article

Hanan Mohamed Abd ElMoneim, Heba Mohamed Tawfik, Yaser Makram El Sherbiny and Ehab Rifat Tawfiek, 2011. Analysia of Her2/neu Overexpression and Amplification in Urothelial Carcinoma of the Bladder Associated with Cox-2 overexpression. International Journal of Cancer Research, 7: 8-24.

DOI: 10.3923/ijcr.2011.8.24

URL: https://scialert.net/abstract/?doi=ijcr.2011.8.24

Leave a Comment

Your email address will not be published. Required fields are marked *